A reassessment of the mechanism of reserpine-produced sedation.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002531:Cerebellum / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008526:Medulla Oblongata / Q000187:drug effects; D010649:Phenylalanine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism; D014316:Tritium
D014316:Tritium; D012701:Serotonin; D010649:Phenylalanine; D012110:Reserpine; D004298:Dopamine